NPDR
Showing 1 - 25 of 90
Non Proliferative Diabetic Retinopathy(NPDR) Trial in Tianjin (pars plana vitrectomy(PPV), Pars plana vitrectomy(PPV)
Not yet recruiting
- Non Proliferative Diabetic Retinopathy(NPDR)
- pars plana vitrectomy(PPV)
- +2 more
-
Tianjin, ChinaTianjin medical university eye hospital
May 10, 2023
NPDR - Non Proliferative Diabetic Retinopathy Trial in Coimbra (Laboratory tests)
Completed
- NPDR - Non Proliferative Diabetic Retinopathy
- Laboratory tests
-
Coimbra, PortugalAIBILI- Association for Biomedical Research and Inovation on Lig
Oct 11, 2022
Nonproliferative Diabetic Retinopathy Trial (EYP-1901, Sham IVT)
Not yet recruiting
- Nonproliferative Diabetic Retinopathy
- EYP-1901
- Sham IVT
- (no location specified)
Aug 3, 2022
Cystoid Macular Edema Following Cataract Surgery Trial in Zagreb (Bromfenac Ophthalmic 0.09% Ophthalmic Solution, Dexamethasone
Completed
- Cystoid Macular Edema Following Cataract Surgery
- Bromfenac Ophthalmic 0.09% Ophthalmic Solution
- +3 more
-
Zagreb, Grad Zagreb, CroatiaKBCZagreb
May 15, 2022
Prophylactic PRP in Moderate NPDR
Completed
- Eye Diseases
- +2 more
- PRP
-
Assiut, EgyptAssiut University
Sep 14, 2022
Eyes With Non Proliferative Diabetic Retinopathy in Diabetes
Recruiting
- NPDR - Non Proliferative Diabetic Retinopathy
- +2 more
- Biomarkers
-
Dijon, France
- +4 more
Jul 18, 2022
Dyslipidemia and Diabetic Retinopathy
Recruiting
- Diabetic Retinopathy
- Dyslipidemia
- 15 subjects with Non Proliferative Diabetic Retinopathy(mild, moderate and severe). 15 subjects with Proliferative Diabetic Retinopathy
- Healthy Controls 15 age matched control subjects
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Aug 11, 2022
Non-Proliferative Diabetic Retinopathy Trial in Puerto Rico, United States (Faricimab)
Not yet recruiting
- Non-Proliferative Diabetic Retinopathy
-
Bakersfield, California
- +18 more
Jan 25, 2023
Non Proliferative Diabetic Retinopathy Trial in Guangzhou (Prompt panretinal photocoagulation, 25G Pars-plana vitrectomy)
Recruiting
- Non Proliferative Diabetic Retinopathy
- Prompt panretinal photocoagulation
- 25G Pars-plana vitrectomy
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
Apr 20, 2021
Non-proliferative Diabetic Retinopathy Trial in Puerto Rico, United States (KSI-301, Sham injection)
Active, not recruiting
- Non-proliferative Diabetic Retinopathy
- KSI-301
- Sham injection
-
Phoenix, Arizona
- +46 more
Sep 22, 2022
Diabetic Retinopathy, Posterior Vitreous Detachment, Disease Progression Trial in Worldwide (ocriplasmin 0.0625mg, ocriplasmin
Terminated
- Diabetic Retinopathy
- +2 more
- ocriplasmin 0.0625mg
- +2 more
-
Phoenix, Arizona
- +37 more
Dec 8, 2020
Diabetic Retinopathy Trial in Bulgaria, United Kingdom (Finerenone (BAY94-8862), Placebo)
Completed
- Diabetic Retinopathy
- Finerenone (BAY94-8862)
- Placebo
-
Dimitrovgrad, Bulgaria
- +10 more
Oct 31, 2022
Maculopathy Trial in Assiut (non steroidal anti inflammatory drugs)
Not yet recruiting
- Maculopathy
- non steroidal anti inflammatory drugs
-
Assiut, Egypt
- +1 more
Jan 8, 2023
s Data From Routine Eye Examinations of Patients Participating
Completed
- Diabetic Retinopathy
- Finerenone (BAY94-8862)
-
Chula Vista, California
- +61 more
Jun 24, 2022
UK Imaging Diabetes Study Seeing Diabetes Clearly
Enrolling by invitation
- Type2 Diabetes
- Diabetic Retinopathy
-
London, United KingdomMoorfields Eye Hospital NHS Foundation Trust
Oct 14, 2022
Comparing 3 Imaging Systems
Recruiting
- Diabetic Retinopathy
- Topcon Camera
- +2 more
-
Madison, WisconsinUW Health - University Station Clinic
Aug 2, 2022
Prediction of Progression of Retinal Ischemia in Diabetes
Recruiting
- Diabetic Retinopathy
-
Coimbra, PortugalAIBILI-CEC (AIBILI- Clinical Trials Centre)
Dec 21, 2022
Non-proliferative Diabetic Retinopathy Trial in United States (OPL-0401 Dose 1, OPL-0401 Dose 2, Placebo)
Recruiting
- Non-proliferative Diabetic Retinopathy
- OPL-0401 Dose 1
- +2 more
-
Mountain View, California
- +20 more
Dec 16, 2022
Diabetic Retinopathy, Diabetic Macular Edema, Diabetic Maculopathy Trial (Screening of DR and DME with artificial intelligence
Not yet recruiting
- Diabetic Retinopathy
- +2 more
- Screening of DR and DME with artificial intelligence using NeoRetina
- +2 more
- (no location specified)
Jul 4, 2022
Diabetic Retinopathy Using a Smartphone-based Camera
Completed
- Diabetic Retinopathy
- Colour fundus photography
-
Manchester, United KingdomDr Edward Jude
Aug 30, 2022
Non-Proliferative Diabetic Retinopathy, Proliferative Diabetic Retinopathy New Vessels on Disc, Dry Eye Syndromes Trial (Sodium
Unknown status
- Non-Proliferative Diabetic Retinopathy
- +2 more
- Sodium Hyaluronate, Vitamin A, Vitamin E
- (no location specified)
Jun 26, 2019
Diabetic Retinopathy Trial in Nashville (Ketorolac 0.45% ophthalmic solution, Placebo - Preservative-free artificial tears,
Recruiting
- Diabetic Retinopathy
- Ketorolac 0.45% ophthalmic solution
- +2 more
-
Nashville, TennesseeVanderbilt University Medical Center
Feb 16, 2022
Severe Nonproliferative Diabetic Retinopathy, Diabetic Retinopathy, Diabete Mellitus Trial in Shanghai (Conbercept, Panretinal
Unknown status
- Severe Nonproliferative Diabetic Retinopathy
- +2 more
- Conbercept
- Panretinal coagulation
-
Shanghai, Shanghai, ChinaRuijin Hospital
Mar 3, 2019
Diabetic Retinopathy Trial in Cairo (Dapagliflozin 10mg Tab plus another oral hypoglycemic agent, Two oral hypoglycemic agents
Recruiting
- Diabetic Retinopathy
- Dapagliflozin 10mg Tab plus another oral hypoglycemic agent
- Two oral hypoglycemic agents other than dapagliflozin
-
Cairo, EgyptInternal medicine and endocrinology department, Ain-shams univer
Jun 9, 2022